Research Associate – tRNA and mRNA Biology
Cambridge, MassachusettsOn-siteFull-time
AI Summary
Research Associate establishing cellular assays for tRNA therapeutic leads in neurobiology, designing and executing in vitro disease models in primary neurons, iPSCs, and rodent cell lines to characterize efficacy and safety.
About this role
Scismic is supporting the growth of a Cambridge, MA biotech startup that is pioneering mRNA-modulating therapies to cure a broad range of genetic diseases. The company is exploring the use of its novel platforms in neurological disorders, heart disease, and muscular dystrophies.
Position summary:
As an expert scientist in cellular neurobiology, you will be responsible for establishing cellular assays to demonstrate in vitro proof of concept for company tRNA therapeutic leads and characterize the cellular activity and downstream disease-relevant biology to help prioritize candidates for in vivo studies.
Key responsibilities for this position include:
Minimum qualifications:
Skills
AAVCalcium ImagingCell CultureIPSCLentivirusMicroscopyMolecular BiologyMulti-electrode ArraysNeurophysiologyPrimary NeuronsQPCRSynaptic ImagingTRNA TherapeuticsWestern Blot
Explore related jobs
More jobs at scismic
Similar AAV jobs
- Senior Scientist II / Principal Scientist I, Biologics Drug Product DevelopmentAbbvie · North Chicago, IL
- Technicien (H/F) - Expérimentation animaleInovarion · Strasbourg, France
- Process Development Engineer II, Advanced Therapy Project Management (ATPM)Regeneron Pharmaceuticals, Inc (USA) · TARRYTOWN
Browse these categories
Market data for this role
All reports →- SeriesRole reportsOne role family at a time: how many openings, what changed this week, who is hiring, what it pays.
- SeriesSalary reportsWhat employers publish in job postings, by level and workplace. Not self-reported pay.
- Market overviewState of tech hiring, September 2026: up 4.8%Tech hiring rose 4.8% month over month in September 2026, with 411,122 new listings. Customer support and account executive roles led the growth.
